What is the treatment for a patient with a systemic allergic reaction, possibly with a history of asthma or other respiratory conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Systemic Allergic Reaction (Anaphylaxis)

Administer epinephrine 0.3-0.5 mg intramuscularly (1:1000 dilution) into the anterolateral thigh immediately—this is the only first-line treatment and must not be delayed. 1, 2, 3

Immediate Management Algorithm

First-Line Treatment: Epinephrine

  • Inject epinephrine IM into the mid-outer thigh at 0.3-0.5 mg for adults (0.01 mg/kg for children, maximum 0.3 mg) using 1:1000 concentration 2, 4, 3
  • Repeat every 5-15 minutes as needed if symptoms persist or progress 1, 2, 5
  • Do not delay epinephrine administration for any reason—delayed injection is associated with fatalities 1, 4
  • Epinephrine is the only medication that acutely reverses anaphylaxis symptoms; antihistamines and corticosteroids are not substitutes 2, 4, 6

Immediate Supportive Measures

  • Position patient supine with legs elevated (unless respiratory distress present, then position of comfort) 2, 4
  • Establish IV access and administer crystalloid bolus: 500-1000 mL for adults or 20 mL/kg for children 2, 5
  • Provide supplemental oxygen and monitor oxygen saturation continuously 2, 5
  • Monitor vital signs closely: blood pressure, heart rate, respiratory rate, oxygen saturation 2, 5

Second-Line Adjunctive Medications

Antihistamines (After Epinephrine)

  • H1-antagonist: Diphenhydramine 25-50 mg IV/IM (1-2 mg/kg) 1, 2, 5, 7
  • H2-antagonist: Ranitidine 50 mg IV (or famotidine 20 mg IV if unavailable) 2, 5
  • The combination of H1 + H2 antagonists is superior to H1 alone 2, 5
  • These provide symptom relief but do not treat the acute life-threatening aspects of anaphylaxis 2, 7

Corticosteroids (After Epinephrine)

  • Methylprednisolone 1-2 mg/kg IV every 6 hours (typically 40 mg IV every 6 hours for 70 kg adult) 1, 2, 5
  • Alternative: Hydrocortisone 100 mg IV 2
  • Corticosteroids provide no acute benefit but may prevent biphasic reactions (occurring in up to 20% of cases) 2, 5, 4
  • Never use corticosteroids as first-line treatment instead of epinephrine 5

Management of Persistent Symptoms

For Refractory Hypotension

  • If hypotension persists despite epinephrine and adequate fluid resuscitation, consider epinephrine IV infusion at 5-15 μg/min 2
  • Alternative vasopressors: Dopamine 2-20 μg/kg/min or vasopressin 0.01-0.04 U/min 2, 5

For Persistent Bronchospasm

  • Administer albuterol nebulization 2.5-5 mg in 3 mL saline if bronchospasm is unresponsive to epinephrine 2

Special Population: Patients on Beta-Blockers

  • These patients are at higher risk for severe anaphylaxis and may be refractory to epinephrine 1
  • If unresponsive to multiple epinephrine doses and fluids, administer glucagon 1-5 mg IV over 5 minutes (20-30 μg/kg for children, maximum 1 mg), followed by infusion at 5-15 μg/min 1, 2, 5
  • Glucagon bypasses beta-receptors and can reverse refractory bronchospasm and hypotension 1, 2

High-Risk Patients Requiring Extra Caution

Asthma Patients

  • Patients with asthma, particularly poorly controlled asthma, are at higher risk for serious systemic reactions 1
  • Consider measuring peak expiratory flow rate before any allergen exposure; withhold allergen immunotherapy if significantly below baseline 1
  • These patients may require longer observation periods and should carry injectable epinephrine 1

Observation and Monitoring

Duration of Observation

  • Observe all patients for minimum 4-6 hours after symptom resolution 2, 4
  • Extend observation to at least 24 hours for severe reactions 5
  • Biphasic reactions can occur up to 72 hours after initial reaction (average 11 hours), with higher risk in patients requiring multiple epinephrine doses 5, 4
  • Most initial reactions occur within 20-30 minutes, but late reactions do occur 1

Discharge Planning

Mandatory Prescriptions

  • Two epinephrine auto-injectors (0.15 mg if 10-25 kg, 0.3 mg if ≥25 kg) with hands-on training demonstration 2, 4
  • Prednisone 1 mg/kg daily (maximum 60-80 mg) for 2-3 days (no taper needed for short course) 2
  • H1-antihistamine for 2-3 days 2
  • H2-antihistamine (ranitidine) twice daily for 2-3 days 2

Patient Education and Follow-Up

  • Provide written anaphylaxis emergency action plan 2, 4
  • Educate on recognition of early symptoms and proper auto-injector technique 2, 4
  • Consider medical identification jewelry 4
  • Schedule follow-up with allergist within 1-2 weeks for formal allergy testing and long-term management 2, 4

Critical Pitfalls to Avoid

  • Never delay or withhold epinephrine while waiting for IV access or other interventions 1, 5, 4
  • Never substitute antihistamines or bronchodilators for epinephrine as first-line treatment 2, 5, 4
  • Never administer epinephrine IV in non-cardiac arrest situations without adequate monitoring 5
  • Never discharge patients prematurely without adequate observation for biphasic reactions 5, 4
  • Never prescribe corticosteroids alone without epinephrine auto-injectors 2
  • Do not use subcutaneous epinephrine—intramuscular administration in the thigh provides faster, more reliable absorption 2, 3

Setting Requirements

  • Anaphylaxis treatment must occur in a facility with trained personnel, immediate physician availability, and equipment for managing anaphylaxis 1
  • Required equipment includes: stethoscope, sphygmomanometer, tourniquets, syringes, large-bore IV catheters (14-18 gauge), aqueous epinephrine 1:1000, oxygen delivery equipment, IV fluid setup, injectable antihistamines, injectable corticosteroids, airway management equipment, and glucagon kit 1
  • Regular practice drills for handling systemic reactions should be conducted 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylactic Shock Management in Abdominal Hydatid Cyst Rupture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine in the Management of Anaphylaxis.

The journal of allergy and clinical immunology. In practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.